SCHEMBL7106635

SCHEMBL7106635

CCCC/C=C(\C(=O)CBr)C(=O)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.44
NPSR1 Q6W5P4 3/20 0.42
GLO1 Q04760 1/20 0.42
EP300 Q09472 1/20 0.41
ALDH1A1 P00352 4/20 0.38
TRPA1 O75762 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP2D6 P10635 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
S1PR4 O95977 1/20 0.37
S1PR1 P21453 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
DHODH Q02127 1/20 0.33
SOAT1 P35610 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7106636 1.00 FAAH (0.44) FAAHNPSR1GLO1EP300ALDH1A1
SCHEMBL7107201 0.95 FAAH (0.50) FAAHNPSR1GLO1EP300ALDH1A1
SCHEMBL7107199 0.95 FAAH (0.50) FAAHNPSR1GLO1EP300ALDH1A1
SCHEMBL7104682 0.90 NPSR1 (0.44) FAAHNPSR1GLO1ALDH1A1TRPA1
SCHEMBL7104683 0.90 NPSR1 (0.44) FAAHNPSR1GLO1ALDH1A1TRPA1
SCHEMBL7100073 0.89 ATM (0.42) FAAHNPSR1EP300ALDH1A1MAPT
SCHEMBL7100076 0.89 ATM (0.42) FAAHNPSR1EP300ALDH1A1MAPT
SCHEMBL7105156 0.89 EP300 (0.40) FAAHEP300ALDH1A1HPGD
SCHEMBL7105155 0.89 EP300 (0.40) FAAHEP300ALDH1A1HPGD
SCHEMBL7105792 0.87 FAAH (0.44) FAAHNPSR1EP300ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000939-B1 Producing z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL CO (JP) 2003-09-17 EP disclosed
US-6403572-B1 REACTING ACID SALT OF A 2-AMINOTHIAZOLE COMPOUND WITH INORGANIC ACID SUMITOMO CHEMICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-20020058818-A1 Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL CO., LTD. 2002-05-16 US disclosed
US-6340763-B1 SALT FORMATION AND CRYSTALLIZATION, REACTION OF HALOGENATED COMPOUND AND THIOUREA COMPOUND SUMITOMO CHEMICAL CO., LTD. (JP) 2002-01-22 US disclosed
EP-1000939-A1 Producing z-isomer of hydrogen bromide salt of 2-aminothiazole derivative SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058818-A1 Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative ZYX, H1-0, HAO2 FAAH 4261/4885NPSR1 1455/4885GLO1 2790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.